Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment: Molecular Therapy - Methods & Clinical Development
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | SpringerLink
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
What Is an Angiotensin Converting Enzyme Inhibitor? | Circulation
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
Figure 1 from Angiotensin-Converting Enzyme 2 ( ACE 2 ) in Disease Pathogenesis | Semantic Scholar
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease - ScienceDirect
Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2- Angiotensin-(1-7)-Mas Receptor Axis | Hypertension
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial - The Lancet
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection - ScienceDirect
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
Design of angiotensin converting enzyme inhibitors | Nature Medicine
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Angiotensin-Converting Enzyme - Proteopedia, life in 3D
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
Frontiers | Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) | Journal of Clinical Pathology
